Mazdutide vs Tirzepatide vs Retatrutide Overview Mazdutide vs Tirzepatide vs Retatrutide
Whether you choose the self-administration route or prefer our helping hand, maintaining healthy B12 levels represents a significant step toward reclaiming your energy, mental clarity, and overall health
Heres what the clinical data shows: Most Common: Nausea (affecting 15-44% of users), diarrhea (10-30%), vomiting (7-25%), and constipation (6-24%) Severity: 98.1% of gastrointestinal side effects are mild or moderate, with 99.5% being non-serious Duration: Median duration is 8 days for nausea, 3 days for diarrhea, and 2 days for vomiting Timing: Most side effects occur during initial weeks and dose escalation, declining over time Discontinuation: Only 4.3-10% of users discontinue therapy due to side effects Serious Events: Rare, with no increased risk of pancreatitis or malignancy in clinical trials Management: Slow dose titration, dietary modifications, and hydration significantly reduce symptoms Important Note: Weight loss is NOT caused by side effects
Rath et al
Lilly reported discontinuation rates of 12.2% and 18.2% across the 9 mg and 12 mg arms, respectively, compared to 4% in the placebo group